AngioDynamics to Hold Fiscal Third Quarter Financial Results Conference Call on Tuesday, March 29, 2005

March 22, 2005 at 12:00 AM EST
AngioDynamics to Hold Fiscal Third Quarter Financial Results Conference Call on Tuesday, March 29, 2005

QUEENSBURY, N.Y., Mar 22, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release third quarter results on Tuesday, March 29, 2005 after market close.

Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on March 29th to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (877) 815-7177 from the U.S., or for international callers, please dial (706) 634-1250.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' web site at http://investor.angiodynamics.com/. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the Web site for 12 months. A telephone replay will be available from 7:30 p.m. Eastern Time March 29, 2005 through 11:59 p.m. Eastern Time on March 31 by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 4979020.

About AngioDynamics

AngioDynamics, Inc. designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease. It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA dilation catheters, thrombolytic products, image-guided vascular access products, endovascular laser venous system products, as well as drainage products.

SOURCE: AngioDynamics, Inc.



AngioDynamics, Inc.       
Joe Gerardi, 800-772-6446 x115       
www.AngioDynamics.com     
or
Investor Relations Contacts:     
Lippert/Heilshorn & Associates, Inc. 
Kim Sutton Golodetz, 212-838-3777 
kgolodetz@lhai.com  
Bruce Voss, 310-691-7100      
bvoss@lhai.com